Skip to main content

177 Lu-PSMA-617 radioligand therapy for biohemically recurrent prostate cancer

von Eyben
Finn
Center
Center of Tobacco Control Research
Odense
Denmark
Show all authors
Kiljunen
Timo
Hospital
Docrates Cancer Center
Helsinki
Finland
Joensuu
Timo
Clinic
Docrates Cancer Center
Helsinki
Finland
Kairemo
Kalevi
Clinic
Docrates Cancer Center
Helsinki
Finland
Virgolini
Irene
Nuclear Medicine
University Hospital Innsbruck
Innsbruck
Austria

Tabs

Speciality: 
Radiotherapy
Keywords: 
lutetium radiotracer-labeled prostate membrane specific antigen radioligand therapy, comparative study, cross-over design